Inflammatory Bowel Disease Drug Attacks Safe Haven for HIV (2 of 2) (IMAGE)

American Association for the Advancement of Science (AAAS)

Inflammatory Bowel Disease Drug Attacks Safe Haven for HIV (2 of 2)

Caption

The researchers' anti-integrin therapy using the approved medication vedolizumab (VDZ) reduced aggregates of immune cells (green) in intestinal biopsies from a patient with HIV and IBD. This material relates to a paper that appeared in the Oct. 3, 2018, issue of Science Translational Medicine, published by AAAS. The paper, by M. Uzzan at Icahn School of Medicine at Mount Sinai in New York, NY, and colleagues was titled, "Anti-a4ß7 therapy targets lymphoid aggregates in the gastrointestinal tract of HIV-1-infected individuals."

Credit

M. Uzzan <i>et al., Science Translational Medicine </i>(2018)

Usage Restrictions

Please cite the owner of the material when publishing. This material may be freely used by reporters as part of news coverage, with proper attribution. Non-reporters must contact <i>Science</i> for permission.

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.